Rezolute, Inc. (RZLT)
5.00
-0.09
(-1.77%)
USD |
NASDAQ |
Aug 24, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Rezolute Price : 5.00 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.68 | 5.635 | 4.646 | 5.09 | 6.501M |
| Aug 20, 2026 | 4.68 | 4.71 | 4.60 | 4.66 | 971465.0 |
| Aug 19, 2026 | 4.77 | 4.87 | 4.65 | 4.72 | 1.220M |
| Aug 18, 2026 | 4.62 | 4.72 | 4.58 | 4.66 | 912778.0 |
| Aug 17, 2026 | 4.58 | 4.695 | 4.56 | 4.68 | 535242.0 |
| Aug 14, 2026 | 4.59 | 4.75 | 4.44 | 4.60 | 657137.0 |
| Aug 13, 2026 | 4.74 | 4.885 | 4.58 | 4.60 | 800613.0 |
| Aug 12, 2026 | 4.65 | 4.805 | 4.62 | 4.70 | 2.391M |
| Aug 11, 2026 | 4.68 | 4.725 | 4.61 | 4.62 | 641978.0 |
| Aug 10, 2026 | 4.68 | 4.760 | 4.595 | 4.68 | 756464.0 |
| Aug 07, 2026 | 4.76 | 4.840 | 4.545 | 4.69 | 986261.0 |
| Aug 06, 2026 | 4.715 | 4.925 | 4.65 | 4.70 | 924974.0 |
| Aug 05, 2026 | 5.03 | 5.04 | 4.66 | 4.68 | 1.374M |
| Aug 04, 2026 | 4.96 | 5.25 | 4.955 | 4.97 | 2.541M |
| Aug 03, 2026 | 4.542 | 4.945 | 4.51 | 4.91 | 1.428M |
| Jul 31, 2026 | 4.91 | 4.91 | 4.545 | 4.72 | 776976.0 |
| Jul 30, 2026 | 4.72 | 4.935 | 4.66 | 4.88 | 805805.0 |
| Jul 29, 2026 | 4.93 | 4.99 | 4.68 | 4.70 | 802434.0 |
| Jul 28, 2026 | 4.92 | 5.03 | 4.81 | 4.92 | 980119.0 |
| Jul 27, 2026 | 4.95 | 5.13 | 4.805 | 4.94 | 1.245M |
| Jul 24, 2026 | 5.31 | 5.31 | 4.898 | 4.99 | 1.147M |
| Jul 23, 2026 | 4.94 | 5.395 | 4.91 | 5.31 | 2.164M |
| Jul 22, 2026 | 5.03 | 5.11 | 4.90 | 5.00 | 854105.0 |
| Jul 21, 2026 | 4.53 | 5.090 | 4.50 | 5.09 | 1.416M |
| Jul 20, 2026 | 4.60 | 4.71 | 4.395 | 4.45 | 1.276M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 14.32 |
| AbbVie, Inc. | 264.49 |
| Marker Therapeutics, Inc. | 1.50 |
| Avalo Therapeutics, Inc. | 19.26 |
| Krystal Biotech, Inc. | 341.78 |
Price Related Metrics
| Price to Book Value | 4.121 |
| Earnings Yield | -16.18% |
| Market Cap | 481.46M |